SARS-CoV-2 vaccination in IBD: more pros than cons.

D'Amico F, Rabaud C, Peyrin-Biroulet L, Danese S

DOI: 10.1038/s41575-021-00420-w
Published: 2021 Apr
Container: Nature reviews. Gastroenterology & hepatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41575-021-00420-w,
  title = {SARS-CoV-2 vaccination in IBD: more pros than cons.},
  author = {D'Amico F and Rabaud C and Peyrin-Biroulet L and Danese S},
  year = {2021},
  journal = {Nature reviews. Gastroenterology \& hepatology},
  doi = {10.1038/s41575-021-00420-w},
  url = {https://doi.org/10.1038/s41575-021-00420-w}
}

RIS

TY  - JOUR
TI  - SARS-CoV-2 vaccination in IBD: more pros than cons.
AU  - D'Amico F
AU  - Rabaud C
AU  - Peyrin-Biroulet L
AU  - Danese S
PY  - 2021
JO  - Nature reviews. Gastroenterology & hepatology
DO  - 10.1038/s41575-021-00420-w
UR  - https://doi.org/10.1038/s41575-021-00420-w
ER  -

APA

F, D., C, R., L, P., & S, D. (2021). SARS-CoV-2 vaccination in IBD: more pros than cons.. Nature reviews. Gastroenterology & hepatology. https://doi.org/10.1038/s41575-021-00420-w

Source records

pubmed · retrieved 2026-09-27T12:23:11.134Z